275 related articles for article (PubMed ID: 38540087)
1. Animal Models for Understanding the Mechanisms of Beta Cell Death during Type 2 Diabetes Pathogenesis.
Covington BA; Chen W
Biomedicines; 2024 Feb; 12(3):. PubMed ID: 38540087
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetes.
Yang CH; Ann-Onda D; Lin X; Fynch S; Nadarajah S; Pappas EG; Liu X; Scott JW; Oakhill JS; Galic S; Shi Y; Moreno-Asso A; Smith C; Loudovaris T; Levinger I; Eizirik DL; Laybutt DR; Herzog H; Thomas HE; Loh K
Mol Metab; 2022 Jan; 55():101413. PubMed ID: 34890851
[TBL] [Abstract][Full Text] [Related]
3. (Epi)genomic heterogeneity of pancreatic islet function and failure in type 2 diabetes.
Lawlor N; Stitzel ML
Mol Metab; 2019 Sep; 27S(Suppl):S15-S24. PubMed ID: 31500827
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional control of pancreatic β-cell identity and plasticity during the pathogenesis of type 2 diabetes.
Zhang Z; Gao Y; Meng ZX
J Genet Genomics; 2022 Apr; 49(4):316-328. PubMed ID: 35292418
[TBL] [Abstract][Full Text] [Related]
5. Elovl6 Deficiency Improves Glycemic Control in Diabetic
Zhao H; Matsuzaka T; Nakano Y; Motomura K; Tang N; Yokoo T; Okajima Y; Han SI; Takeuchi Y; Aita Y; Iwasaki H; Yatoh S; Suzuki H; Sekiya M; Yahagi N; Nakagawa Y; Sone H; Yamada N; Shimano H
Diabetes; 2017 Jul; 66(7):1833-1846. PubMed ID: 28461456
[TBL] [Abstract][Full Text] [Related]
6. Identification of type 2 diabetes- and obesity-associated human β-cells using deep transfer learning.
Roy G; Syed R; Lazaro O; Robertson S; McCabe SD; Rodriguez D; Mawla AM; Johnson TS; Kalwat MA
bioRxiv; 2024 Jan; ():. PubMed ID: 38328172
[TBL] [Abstract][Full Text] [Related]
7. Evidence against a role for NLRP3-driven islet inflammation in db/db mice.
Kammoun HL; Allen TL; Henstridge DC; Barre S; Coll RC; Lancaster GI; Cron L; Reibe S; Chan JY; Bensellam M; Laybutt DR; Butler MS; Robertson AAB; O'Neill LA; Cooper MA; Febbraio MA
Mol Metab; 2018 Apr; 10():66-73. PubMed ID: 29478918
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Effects of Adipose Stem Cells from Diabetic Mice for the Treatment of Type 2 Diabetes.
Wang M; Song L; Strange C; Dong X; Wang H
Mol Ther; 2018 Aug; 26(8):1921-1930. PubMed ID: 30005867
[TBL] [Abstract][Full Text] [Related]
9. Protein Kinases Signaling in Pancreatic Beta-cells Death and Type 2 Diabetes.
Engin AB; Engin A
Adv Exp Med Biol; 2021; 1275():195-227. PubMed ID: 33539017
[TBL] [Abstract][Full Text] [Related]
10. Voluntary running exercise prevents β-cell failure in susceptible islets of the Zucker diabetic fatty rat.
Delghingaro-Augusto V; Décary S; Peyot ML; Latour MG; Lamontagne J; Paradis-Isler N; Lacharité-Lemieux M; Akakpo H; Birot O; Nolan CJ; Prentki M; Bergeron R
Am J Physiol Endocrinol Metab; 2012 Jan; 302(2):E254-64. PubMed ID: 22045312
[TBL] [Abstract][Full Text] [Related]
11. Zucker Diabetic-Sprague Dawley (ZDSD) rat: Type 2 diabetes translational research model.
Wang AN; Carlos J; Fraser GM; McGuire JJ
Exp Physiol; 2022 Apr; 107(4):265-282. PubMed ID: 35178802
[TBL] [Abstract][Full Text] [Related]
12. Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis.
Kim JY; Park KJ; Hwang JY; Kim GH; Lee D; Lee YJ; Song EH; Yoo MG; Kim BJ; Suh YH; Roh GS; Gao B; Kim W; Kim WH
J Hepatol; 2017 Aug; 67(2):349-359. PubMed ID: 28365312
[TBL] [Abstract][Full Text] [Related]
13. Genetic lineage tracing identifies adaptive mechanisms of pancreatic islet β cells in various mouse models of diabetes with distinct age of initiation.
Fu Q; Qian Y; Jiang H; He Y; Dai H; Chen Y; Xia Z; Liang Y; Zhou Y; Gao R; Zheng S; Lv H; Sun M; Xu K; Yang T
Sci China Life Sci; 2024 Mar; 67(3):504-517. PubMed ID: 37930473
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Signaling Pathways Associated with Pancreatic β-cell Adaptive Flexibility in Compensation of Obesity-linked Diabetes in
Kang T; Boland BB; Jensen P; Alarcon C; Nawrocki A; Grimsby JS; Rhodes CJ; Larsen MR
Mol Cell Proteomics; 2020 Jun; 19(6):971-993. PubMed ID: 32265294
[TBL] [Abstract][Full Text] [Related]
15. Proper mTORC1 Activity Is Required for Glucose Sensing and Early Adaptation in Human Pancreatic β Cells.
Ni Q; Song J; Wang Y; Sun J; Xie J; Zhang J; Ning G; Wang W; Wang Q
J Clin Endocrinol Metab; 2021 Jan; 106(2):e562-e572. PubMed ID: 33120423
[TBL] [Abstract][Full Text] [Related]
16. Treatment for type 2 diabetes and diabetic nephropathy by targeting Smad3 signaling.
He H; Wang H; Chen X; Zhong Y; Huang XR; Ma RC; Wang C; Lan HY
Int J Biol Sci; 2024; 20(1):200-217. PubMed ID: 38164169
[TBL] [Abstract][Full Text] [Related]
17. Role of pancreatic β-cell death and inflammation in diabetes.
Quan W; Jo EK; Lee MS
Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():141-51. PubMed ID: 24003931
[TBL] [Abstract][Full Text] [Related]
18. The protective role of shenqi compound in type 2 diabetes: A comprehensive investigation of pancreatic β-cell function and mass.
Yang C; Liu H; Xie Z; Yang Q; Du L; Xie C
Biomed Pharmacother; 2023 Oct; 166():115287. PubMed ID: 37572639
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of research-focused human islet preparations from organ donors with type 2 diabetes.
Liang R; Sun P; Cai X; Liu T; Wang L; Liu N; Ding X; Zhang B; Liu Z; Zou J; Wang S
Islets; 2023 Dec; 15(1):2219104. PubMed ID: 37314095
[TBL] [Abstract][Full Text] [Related]
20. The entero-insular axis: implications for human metabolism.
Ranganath LR
Clin Chem Lab Med; 2008; 46(1):43-56. PubMed ID: 18020966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
